Gene interactions and pathways from curated databases and text-mining

◀ Back to AKT1

AKT1 — RAD51

Text-mined interactions from Literome

Albert et al., Mol Cancer Ther 2006 (Breast Neoplasms) : Irradiation induced Akt and mTOR signaling, and this signaling is attenuated by RAD001
Mabuchi et al., Cancer Res 2007 (Disease Models, Animal...) : In vivo effects of RAD001 on Akt-mTOR signaling, tumor cell proliferation, and blood vessel area were analyzed by immunohistochemistry and Western blot analysis
Tamburini et al., Blood 2008 (Leukemia, Myeloid, Acute) : In 19 AML samples with constitutive PI3K/Akt activation, the rapamycin derivative inhibitor everolimus ( RAD001 ) increased Akt phosphorylation ... This mTOR C1-mediated Akt up-regulation was explained by an insulin-like growth factor-1 (IGF-1)/IGF-1 receptor autocrine loop : ( 1 ) blast cells expressed functional IGF-1 receptors, and IGF-1 induced Akt activation was increased by RAD001 , ( 2 ) a neutralizing anti-IGF-1R alpha-IR3 monoclonal antibody reversed the RAD001 induced Akt phosphorylation, and ( 3 ) autocrine production of IGF-1 was detected in purified blast cells by quantitative reverse transcription-polymerase chain reaction and immunofluorescence ... This RAD001 induced PI3K/Akt up-regulation was due to an up-regulated expression of the IRS2 adaptor
Breuleux et al., Mol Cancer Ther 2009 (Neoplasms) : In contrast, increased AKT S473 phosphorylation induced by RAD001 did not correlate
Ko et al., Mol Cancer Res 2009 (Carcinoma, Non-Small-Cell Lung...) : Roles of MKK1/2-ERK1/2 and phosphoinositide 3-kinase-AKT signaling pathways in erlotinib induced Rad51 suppression and cytotoxicity in human non-small cell lung cancer cells ... In this study, we investigated the roles of ERK1/2 and AKT signaling pathways in regulating Rad51 expression and cytotoxic effects in different NSCLC cell lines treated with erlotinib ... Blocking the activations of ERK1/2 and AKT by MKK1/2 inhibitor ( U0126 ) and phosphoinositide 3-kinase inhibitor ( wortmannin ) suppressed the expression of Rad51 and enhanced the erlotinib induced cell death in erlotinib-resistant cells
Mancini et al., J Cell Biochem 2010 (Leukemia, Myelogenous, Chronic, BCR-ABL Positive) : Moreover, RAD 001 induced inhibition of Akt causes the de-phosphorylation of tuberous sclerosis tumor suppressor protein TSC2 at 14-3-3 binding sites, TSC2 release from 14-3-3 sigma ( restoring its inhibitory function on mTORC1 ) and nuclear import ( promoting the nuclear translocation of cyclin dependent kinase [ CDK ] inhibitor p27 ( Kip1 ), the stabilization of p27 ( Kip1 ) ligand with CDK2, and the G ( 0 ) /G ( 1 ) arrest )
Tsai et al., J Pharmacol Exp Ther 2010 (Carcinoma, Non-Small-Cell Lung) : Enforced expression of constitutively active MKK1/2 or AKT recovered cell viability and Rad51 protein levels that were decreased by the combination of erlotinib and gemcitabine
Loehberg et al., Biochem Pharmacol 2012 (Breast Neoplasms...) : The anticancer drug RAD001 ( everolimus ) is a known mTOR-inhibitor, but mTOR-inhibition leads to phosphorylation of Akt inducing resistance against RAD001 treatment ... Therefore, our aim was to test, if Chloroquine could inhibit tumor growth and prevent RAD001 induced Akt activation ... The Chloroquine effect of overcoming the RAD001 induced activation of the oncogene Akt , as well as the promising antitumor activity in our mammary tumor animal model present Chloroquine as an interesting combination partner for the mTOR-inhibitor RAD001
Ren et al., Cancer Lett 2012 (Carcinoma, Non-Small-Cell Lung...) : This combination abrogated RAD001 induced Akt phosphorylation and exerted enhanced suppressive effect on 4EBP1 phosphorylation
Chan et al., Cancer Chemother Pharmacol 2013 (Carcinoma, Hepatocellular...) : Although the addition of the TKI258 only slightly suppressed the phosphorylation of AKT induced by RAD001 , the pi-mTOR and its downstream signaling pathways including pi-p70S6K, pi-S6 and pi-4EBP1 were lowered in the combination
Hisamatsu et al., Mol Cancer Ther 2013 : Treatment with RAD001 induced mTORC2 mediated AKT activation in RAD001-sensitive CCC cells